Article Details

Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation

Retrieved on: 2022-12-27 13:46:58

Tags for this article:

Click the tags to see associated articles and topics

Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation. View article details on HISWAI: https://www.marketscreener.com/quote/stock/GEMINI-THERAPEUTICS-INC-118740028/news/Gemini-Therapeutics-Shares-Rise-After-Disc-Medicine-Gets-FDA-Designation-42622531/%3Fcountview%3D0

Excerpt

Gemini Therapeutics shares were up 18% at $1.83 in premarket trading Tuesday after its merger target, Disc Medicine Inc., received orphan drug ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up